Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-γ-dependent manner

Dru S. Dace, Peter W. Chen, Hassan Alizadeh, Jerry Y. Niederkorn

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Although intraocular tumors reside in an immune-privileged site, they can circumvent immune privilege and undergo rejection, which typically follows one of two pathways. One pathway involves CD4+ T cells, delayed-type hypersensitivity (DTH), and the culmination in ischemic necrosis of the tumor and phthisis (atrophy) of the eye. The second pathway is DTH-independent and does not inflict collateral injury to ocular tissues, and the eye is preserved. In this study, we used a well-characterized tumor, Ad5E1, to analyze the role of IFN-γ in the nonphthisical form of intraocular tumor rejection. The results showed that IFN-γ induced tumor cell apoptosis, inhibited tumor cell proliferation, and promoted rejection by inhibiting angiogenesis. Microarray analysis revealed that IFN-γ induced up-regulation of five antiangiogenic genes and down-regulation of four proangiogenic genes in Ad5E1 tumor cells. Although IFN-γ knockout (KO) mice have progressively growing intraocular tumors, IFN-γ was not needed for the elimination of extraocular tumors, as all IFN-γ KO mice rejected s.c. tumor inocula. This represents a heretofore unrecognized role for IFN-γ in circumventing ocular immune privilege and eliminating intraocular tumors. The findings also reveal that some IFN-γ-independent tumor rejection processes are excluded from the eye and may represent a new facet of ocular immune privilege.

Original languageEnglish (US)
Pages (from-to)421-429
Number of pages9
JournalJournal of Leukocyte Biology
Volume81
Issue number2
DOIs
StatePublished - Feb 1 2007

Fingerprint

T-Lymphocytes
Neoplasms
Delayed Hypersensitivity
Knockout Mice
Microarray Analysis
Genes
Atrophy
Necrosis
Up-Regulation
Down-Regulation
Cell Proliferation
Apoptosis
Wounds and Injuries

Keywords

  • Angiogenesis
  • Anterior chamber

ASJC Scopus subject areas

  • Cell Biology

Cite this

Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-γ-dependent manner. / Dace, Dru S.; Chen, Peter W.; Alizadeh, Hassan; Niederkorn, Jerry Y.

In: Journal of Leukocyte Biology, Vol. 81, No. 2, 01.02.2007, p. 421-429.

Research output: Contribution to journalArticle

@article{055955411a55428aa1cf74a4f94cfac7,
title = "Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-γ-dependent manner",
abstract = "Although intraocular tumors reside in an immune-privileged site, they can circumvent immune privilege and undergo rejection, which typically follows one of two pathways. One pathway involves CD4+ T cells, delayed-type hypersensitivity (DTH), and the culmination in ischemic necrosis of the tumor and phthisis (atrophy) of the eye. The second pathway is DTH-independent and does not inflict collateral injury to ocular tissues, and the eye is preserved. In this study, we used a well-characterized tumor, Ad5E1, to analyze the role of IFN-γ in the nonphthisical form of intraocular tumor rejection. The results showed that IFN-γ induced tumor cell apoptosis, inhibited tumor cell proliferation, and promoted rejection by inhibiting angiogenesis. Microarray analysis revealed that IFN-γ induced up-regulation of five antiangiogenic genes and down-regulation of four proangiogenic genes in Ad5E1 tumor cells. Although IFN-γ knockout (KO) mice have progressively growing intraocular tumors, IFN-γ was not needed for the elimination of extraocular tumors, as all IFN-γ KO mice rejected s.c. tumor inocula. This represents a heretofore unrecognized role for IFN-γ in circumventing ocular immune privilege and eliminating intraocular tumors. The findings also reveal that some IFN-γ-independent tumor rejection processes are excluded from the eye and may represent a new facet of ocular immune privilege.",
keywords = "Angiogenesis, Anterior chamber",
author = "Dace, {Dru S.} and Chen, {Peter W.} and Hassan Alizadeh and Niederkorn, {Jerry Y.}",
year = "2007",
month = "2",
day = "1",
doi = "10.1189/jlb.0806489",
language = "English (US)",
volume = "81",
pages = "421--429",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-γ-dependent manner

AU - Dace, Dru S.

AU - Chen, Peter W.

AU - Alizadeh, Hassan

AU - Niederkorn, Jerry Y.

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Although intraocular tumors reside in an immune-privileged site, they can circumvent immune privilege and undergo rejection, which typically follows one of two pathways. One pathway involves CD4+ T cells, delayed-type hypersensitivity (DTH), and the culmination in ischemic necrosis of the tumor and phthisis (atrophy) of the eye. The second pathway is DTH-independent and does not inflict collateral injury to ocular tissues, and the eye is preserved. In this study, we used a well-characterized tumor, Ad5E1, to analyze the role of IFN-γ in the nonphthisical form of intraocular tumor rejection. The results showed that IFN-γ induced tumor cell apoptosis, inhibited tumor cell proliferation, and promoted rejection by inhibiting angiogenesis. Microarray analysis revealed that IFN-γ induced up-regulation of five antiangiogenic genes and down-regulation of four proangiogenic genes in Ad5E1 tumor cells. Although IFN-γ knockout (KO) mice have progressively growing intraocular tumors, IFN-γ was not needed for the elimination of extraocular tumors, as all IFN-γ KO mice rejected s.c. tumor inocula. This represents a heretofore unrecognized role for IFN-γ in circumventing ocular immune privilege and eliminating intraocular tumors. The findings also reveal that some IFN-γ-independent tumor rejection processes are excluded from the eye and may represent a new facet of ocular immune privilege.

AB - Although intraocular tumors reside in an immune-privileged site, they can circumvent immune privilege and undergo rejection, which typically follows one of two pathways. One pathway involves CD4+ T cells, delayed-type hypersensitivity (DTH), and the culmination in ischemic necrosis of the tumor and phthisis (atrophy) of the eye. The second pathway is DTH-independent and does not inflict collateral injury to ocular tissues, and the eye is preserved. In this study, we used a well-characterized tumor, Ad5E1, to analyze the role of IFN-γ in the nonphthisical form of intraocular tumor rejection. The results showed that IFN-γ induced tumor cell apoptosis, inhibited tumor cell proliferation, and promoted rejection by inhibiting angiogenesis. Microarray analysis revealed that IFN-γ induced up-regulation of five antiangiogenic genes and down-regulation of four proangiogenic genes in Ad5E1 tumor cells. Although IFN-γ knockout (KO) mice have progressively growing intraocular tumors, IFN-γ was not needed for the elimination of extraocular tumors, as all IFN-γ KO mice rejected s.c. tumor inocula. This represents a heretofore unrecognized role for IFN-γ in circumventing ocular immune privilege and eliminating intraocular tumors. The findings also reveal that some IFN-γ-independent tumor rejection processes are excluded from the eye and may represent a new facet of ocular immune privilege.

KW - Angiogenesis

KW - Anterior chamber

UR - http://www.scopus.com/inward/record.url?scp=33846654154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846654154&partnerID=8YFLogxK

U2 - 10.1189/jlb.0806489

DO - 10.1189/jlb.0806489

M3 - Article

C2 - 17077163

AN - SCOPUS:33846654154

VL - 81

SP - 421

EP - 429

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 2

ER -